1-4 of 4
Jarushka Naidoo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO008: The mouse colon modulates human microbes in transplantable murine tumor models after human fecal microbiota transfer (FMT)

Free
Fyza Y. Shaikh, Joell J. Gills, James R. White, Fuad Mohammad, Courtney M. Stevens, Jarushka Naidoo, Drew M. Pardoll, Cynthia L. Sears
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (2_Supplement): PO008.
https://doi.org/10.1158/2326-6074.TUMIMM20-PO008
Published: 03 February 2021
View articletitled, Abstract PO008: The mouse colon modulates human microbes in transplantable murine tumor models after human fecal microbiota transfer (FMT)
Journal Articles

The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

Free
Ludmila Danilova, Valsamo Anagnostou, Justina X. Caushi, John-William Sidhom, Haidan Guo, Hok Yee Chan, Prerna Suri, Ada Tam, Jiajia Zhang, Margueritta El Asmar, Kristen A. Marrone, Jarushka Naidoo, Julie R. Brahmer, Patrick M. Forde, Alexander S. Baras, Leslie Cope, Victor E. Velculescu, Drew M. Pardoll, Franck Housseau, Kellie N. Smith
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2018) 6 (8): 888–899.
https://doi.org/10.1158/2326-6066.CIR-18-0129
Published: 31 July 2018
View articletitled, The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Open the PDF for The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Free
Jarushka Naidoo, Katja Schindler, Christiane Querfeld, Klaus Busam, Jane Cunningham, David B. Page, Michael A. Postow, Alyona Weinstein, Anna Skripnik Lucas, Kathryn T. Ciccolini, Elizabeth A. Quigley, Alexander M. Lesokhin, Paul K. Paik, Jamie E. Chaft, Neil H. Segal, Sandra P. D'Angelo, Mark A. Dickson, Jedd D. Wolchok, Mario E. Lacouture
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (5): 383–389.
https://doi.org/10.1158/2326-6066.CIR-15-0123
Published: 01 May 2016
View articletitled, Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1
Open the PDF for Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1 in another window
Journal Articles

Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab

Free
Jianda Yuan, Jun Zhou, Zhiwan Dong, Sapna Tandon, Deborah Kuk, Katherine S. Panageas, Philip Wong, Xinqi Wu, Jarushka Naidoo, David B. Page, Jedd D. Wolchok, F. Stephen Hodi
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (2): 127–132.
https://doi.org/10.1158/2326-6066.CIR-13-0163
Published: 03 February 2014
View articletitled, Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
Open the PDF for Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab in another window